These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18678315)

  • 1. Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure.
    Fragasso G; Salerno A; Margonato A
    Am J Cardiol; 2008 Aug; 102(4):506-7. PubMed ID: 18678315
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers for heart failure: why you should use them more.
    Ong HT; Kow FP
    J Fam Pract; 2011 Aug; 60(8):472-7. PubMed ID: 21814642
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
    de Boer RA; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):261-3. PubMed ID: 18418705
    [No Abstract]   [Full Text] [Related]  

  • 4. We should not hesitate to use beta-blockers for systolic heart failure with concomitant renal dysfunction.
    Matsuda N
    Circ J; 2010 Aug; 74(8):1526-7. PubMed ID: 20647630
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients.
    Ghali JK
    J Am Coll Cardiol; 2005 Mar; 45(5):809; author reply 809-10. PubMed ID: 15734634
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure.
    Fragasso G; Spoladore R; Maranta F; Corti A; Lattuada G; Colombo B; Locatelli M; Salerno A; Calori G; Briceno L; Alfieri AB; Perseghin G; Margonato A
    J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):49-56. PubMed ID: 23018486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.
    Remme WJ
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):99-101. PubMed ID: 16025226
    [No Abstract]   [Full Text] [Related]  

  • 8. Dismantling mandates in the treatment of heart failure.
    Leier CV
    J Am Coll Cardiol; 2004 Nov; 44(9):1831-3. PubMed ID: 15519015
    [No Abstract]   [Full Text] [Related]  

  • 9. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is carvedilol better than other beta-blockers for heart failure?
    Rain C; Rada G
    Medwave; 2015 Jun; 15 Suppl 1():e6168. PubMed ID: 26135382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
    Fujimura M; Akaike M; Iwase T; Yoshida S; Sumitomo Y; Yagi S; Ikeda Y; Hashizume S; Aihara K; Nishiuchi T; Yasumura Y; Matsumoto T
    Acta Cardiol; 2009 Oct; 64(5):589-95. PubMed ID: 20058503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
    Albert NM
    Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
    [No Abstract]   [Full Text] [Related]  

  • 14. Regular Treatment Strategy with a Large Amount of Carvedilol for Heart Failure Improves Biventricular Systolic Failure in a Patient with Repaired Tetralogy of Fallot.
    Soma K; Yao A; Saito A; Inaba T; Ishikawa Y; Hirata Y; Komuro I
    Int Heart J; 2018 Sep; 59(5):1169-1173. PubMed ID: 30101848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol.
    Nessler J; Nessler B; Kitliński M; Stepniewski M; Piwowarska W
    Cardiol J; 2008; 15(4):329-37. PubMed ID: 18698541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
    Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of beta-blockade on chronic heart failure.
    Bloomenthal R
    J Fam Pract; 1996 Aug; 43(2):116-7. PubMed ID: 8708614
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockers and congestive heart failure.
    Movahed A
    Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.